These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35787257)

  • 21. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS).
    Jia W; Gao X; Pang C; Hou X; Bao Y; Liu W; Wang W; Zuo Y; Gu H; Xiang K
    Nephrol Dial Transplant; 2009 Dec; 24(12):3724-31. PubMed ID: 19617258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the evidence that microalbuminuria is a predictor of cardiovascular disease events?
    Yuyun MF; Adler AI; Wareham NJ
    Curr Opin Nephrol Hypertens; 2005 May; 14(3):271-6. PubMed ID: 15821422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of microalbuminuria in newly diagnosed type 2 diabetic patients in Jos Nigeria.
    Agaba EI; Agaba PA; Puepet FH
    Afr J Med Med Sci; 2004 Mar; 33(1):19-22. PubMed ID: 15490788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renin inhibition and microalbuminuria development: meaningful predictor of kidney disease progression.
    De Silva L; Weir MR
    Curr Opin Nephrol Hypertens; 2010 Sep; 19(5):437-43. PubMed ID: 20644476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.
    Wachtell K; Olsen MH; Dahlöf B; Devereux RB; Kjeldsen SE; Nieminen MS; Okin PM; Papademetriou V; Mogensen CE; Borch-Johnsen K; Ibsen H
    J Hypertens; 2002 Mar; 20(3):405-12. PubMed ID: 11875307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and methods of the prevalence and pharmacogenomics of tenofovir nephrotoxicity in HIV-positive adults in south-western Nigeria study.
    Hassan MO; Duarte R; Mabayoje VO; Dickens C; Lasisi AO; Naicker S
    BMC Nephrol; 2020 Oct; 21(1):436. PubMed ID: 33066744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of albuminuria in Australia: the AusDiab Kidney Study.
    Atkins RC; Polkinghorne KR; Briganti EM; Shaw JE; Zimmet PZ; Chadban SJ
    Kidney Int Suppl; 2004 Nov; (92):S22-4. PubMed ID: 15485411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microalbuminuria in HIV disease.
    Hadigan C; Edwards E; Rosenberg A; Purdy JB; Fleischman E; Howard L; Mican JM; Sampath K; Oyalowo A; Johnson A; Adler A; Rehm C; Smith M; Lai L; Kopp JB
    Am J Nephrol; 2013; 37(5):443-51. PubMed ID: 23615312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma proteomics classifiers improve risk prediction for renal disease in patients with hypertension or type 2 diabetes.
    Pena MJ; Jankowski J; Heinze G; Kohl M; Heinzel A; Bakker SJ; Gansevoort RT; Rossing P; de Zeeuw D; Heerspink HJ; Jankowski V
    J Hypertens; 2015 Oct; 33(10):2123-32. PubMed ID: 26237555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.
    De Cosmo S; Motterlini N; Prudente S; Pellegrini F; Trevisan R; Bossi A; Remuzzi G; Trischitta V; Ruggenenti P;
    Diabetes; 2009 Dec; 58(12):2920-9. PubMed ID: 19720797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis and treatment of microalbuminuria in patients with diabetes: the road ahead.
    Kalaitzidis R; Bakris G
    J Clin Hypertens (Greenwich); 2009 Nov; 11(11):636-43. PubMed ID: 19878372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of diabetic nephropathy in primary care type 2 diabetic patients with hypertension: data from the Korean Epidemiology Study on Hypertension III (KEY III study).
    Yang CW; Park JT; Kim YS; Kim YL; Lee YS; Oh YS; Kang SW
    Nephrol Dial Transplant; 2011 Oct; 26(10):3249-55. PubMed ID: 21372264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Albuminuria, cardiovascular risk factors and disease management in subjects with type 2 diabetes: a cross sectional study.
    Meisinger C; Heier M; Landgraf R; Happich M; Wichmann HE; Piehlmeier W
    BMC Health Serv Res; 2008 Nov; 8():226. PubMed ID: 18986536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.
    de Boer IH; Gao X; Cleary PA; Bebu I; Lachin JM; Molitch ME; Orchard T; Paterson AD; Perkins BA; Steffes MW; Zinman B;
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1969-1977. PubMed ID: 27797889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Albuminuria Is Associated with Traditional Cardiovascular Risk Factors and Viral Load in HIV-Infected Patients in Rural South Africa.
    Wensink GE; Schoffelen AF; Tempelman HA; Rookmaaker MB; Hoepelman AI; Barth RE
    PLoS One; 2015; 10(8):e0136529. PubMed ID: 26309226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burden and pattern of micro vascular complications in type 2 diabetes in a tertiary health institution in Nigeria.
    Olamoyegun M; Ibraheem W; Iwuala S; Audu M; Kolawole B
    Afr Health Sci; 2015 Dec; 15(4):1136-41. PubMed ID: 26958014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Asymptomatic Microalbuminuria in HIV Positive Children in India.
    Sharma G; Mathai SS
    Indian J Pediatr; 2017 Jun; 84(6):417-419. PubMed ID: 28176231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.
    de Boer IH; Rue TC; Cleary PA; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B; Brunzell JD; ; White NH; Danis RP; Davis MD; Hainsworth D; Hubbard LD; Nathan DM
    Arch Intern Med; 2011 Mar; 171(5):412-20. PubMed ID: 21403038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.